Single agent daratumumab in advanced multiple myeloma possesses significant efficacy even in an unselected "real-world" population.
第一作者:
Jiri,Minarik
第一单位:
Department of Hemato-oncology, University Hospital Olomouc and Faculty of Medicine, Palacky University Olomouc, Czech Republic.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);肿瘤复发, 局部(Neoplasm Recurrence, Local);复发(Recurrence);治疗结果(Treatment Outcome)
DOI
10.5507/bp.2018.064
PMID
30397362
发布时间
2020-02-24
- 浏览9

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文